Find Alfaxalone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

10 RELATED EXCIPIENT COMPANIES

18EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Alphaxalone, 23930-19-0, 5alpha-pregnan-3alpha-ol-11,20-dione, Alfaxalonum [inn-latin], Alfaxalona [inn-spanish], Gr 2/234
Molecular Formula
C21H32O3
Molecular Weight
332.5  g/mol
InChI Key
DUHUCHOQIDJXAT-OLVMNOGESA-N
FDA UNII
BD07M97B2A

Alfaxalone
Alfaxalone is a synthetic neuroactive steroid, with anesthetic activity. Upon administration, alfaxalone binds to the gamma-aminobutyric acid (GABA)-A cell surface receptor, thereby enhancing the inhibitory actions of GABA-A in the brain. This leads to modulation of neuronal cell membrane chloride ion transport and induction and maintenance of anesthesia.
1 2D Structure

Alfaxalone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one
2.1.2 InChI
InChI=1S/C21H32O3/c1-12(22)16-6-7-17-15-5-4-13-10-14(23)8-9-20(13,2)19(15)18(24)11-21(16,17)3/h13-17,19,23H,4-11H2,1-3H3/t13-,14+,15-,16+,17-,19+,20-,21+/m0/s1
2.1.3 InChI Key
DUHUCHOQIDJXAT-OLVMNOGESA-N
2.1.4 Canonical SMILES
CC(=O)C1CCC2C1(CC(=O)C3C2CCC4C3(CCC(C4)O)C)C
2.1.5 Isomeric SMILES
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C
2.2 Other Identifiers
2.2.1 UNII
BD07M97B2A
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Alfaxolone

2. Alphaxalone

3. Alphaxalone, (3alpha)-isomer

4. Alphaxalone, (3alpha,5beta)-isomer

5. Alphaxalone, (3beta,5alpha)-isomer

6. Alphaxalone, (3beta,5beta)-isomer

7. Delta(16)-alfaxalone

8. Hydroxy-5 Alpha-pregnane-11,20-dione

2.3.2 Depositor-Supplied Synonyms

1. Alphaxalone

2. 23930-19-0

3. 5alpha-pregnan-3alpha-ol-11,20-dione

4. Alfaxalonum [inn-latin]

5. Alfaxalona [inn-spanish]

6. Gr 2/234

7. Phaxan

8. 3alpha-hydroxy-5alpha-pregnane-11,20-dione

9. (3r,5s,8s,9s,10s,13s,14s,17s)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one

10. Alfadione

11. Mls000069684

12. Mls001076262

13. Bd07m97b2a

14. Chembl190279

15. Chebi:34531

16. Alfaxalone (inn)

17. Ncgc00023100-03

18. Smr000058494

19. (3a,5a)-3-hydroxypregnane-11,20-dione

20. Alfaxalone [inn]

21. Dsstox_cid_2576

22. Dsstox_rid_76638

23. Alphaxolone

24. Dsstox_gsid_22576

25. Alfaxalona

26. Alfaxalonum

27. Sr-01000000168

28. Brn 3217240

29. Unii-bd07m97b2a

30. 3alpha-hydroxy-5alpha-pregnan-11,20-dion

31. 5alpha-alphaxalone

32. Alfaxalone [inn:ban:dcf:jan]

33. 3-alpha-hydroxy-5-alpha-pregnane-11,20-dione

34. (3-alpha,5-alpha)-3-hydroxypregnane-11,20-dione

35. Cas-23930-19-0

36. Alfaxalone [mi]

37. 3.alpha.-hydroxy-5.alpha.-pregnane-11,20-dione

38. Alfaxalone [jan]

39. Opera_id_1629

40. Prestwick0_001002

41. Prestwick1_001002

42. Prestwick2_001002

43. Prestwick3_001002

44. Alfaxalone [mart.]

45. Alfaxalone [who-dd]

46. (3alpha,5alpha)-3-hydroxypregnane-11,20-dione

47. Bidd:pxr0037

48. Lopac0_000929

49. Pregnane-11,20-dione, 3-hydroxy-, (3a,5a)-

50. Schembl57756

51. Bspbio_001123

52. 4-08-00-02091 (beilstein Handbook Reference)

53. 5-alpha-pregnane-11,20-dione, 3-alpha-hydroxy-

54. Spbio_003004

55. Bpbio1_001237

56. Gtpl5461

57. Alfaxalone [green Book]

58. Dtxsid9022576

59. Pregnane-11,20-dione, 3-hydroxy-, (3-alpha,5-alpha)-

60. Hms1571i05

61. Hms2098i05

62. Hms2236n05

63. Hms3262j20

64. Hms3715i05

65. Zinc4081122

66. Tox21_110884

67. Tox21_500929

68. Bdbm50164570

69. Akos024457399

70. Tox21_110884_1

71. Ccg-205010

72. Db11371

73. Lp00929

74. Sdccgsbi-0050903.p002

75. 5alpha-pregnane-3alpha-ol-11,20-dione

76. Ncgc00023100-04

77. Ncgc00023100-05

78. Ncgc00023100-06

79. Ncgc00023100-08

80. Ncgc00261614-01

81. Gr-2/234

82. (3?,5?)-3-hydroxypregnane-11,20-dione

83. Ab00384358

84. B7253

85. Eu-0100929

86. D07282

87. P 5052

88. Sr-01000076070

89. J-015280

90. Q3611058

91. Sr-01000000168-2

92. Sr-01000000168-3

93. Sr-01000076070-1

94. Brd-k41445866-001-03-0

95. 5alpha-pregnan-3alpha-ol-11,20-dione, Powder, >=98% (tlc)

96. (3beta,5alpha,8alpha,9beta,10alpha)-3-hydroxypregnane-11,20-dione

97. (3r,5s,8s,9s,10s,13s,14s,17s)-17-acetyl-3-hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-11-one

98. Ey4

2.4 Create Date
2005-06-29
3 Chemical and Physical Properties
Molecular Weight 332.5 g/mol
Molecular Formula C21H32O3
XLogP33.2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count1
Exact Mass332.23514488 g/mol
Monoisotopic Mass332.23514488 g/mol
Topological Polar Surface Area54.4 Ų
Heavy Atom Count24
Formal Charge0
Complexity569
Isotope Atom Count0
Defined Atom Stereocenter Count8
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Neurosteroids

Endogenous compounds or drugs that affect neuronal excitability through modulation of specific ionotropic receptors (e.g., GABA-A RECEPTORS). Endogenous neurosteroids are steroid hormones de novo synthesized by neurons and glial cells from steroid metabolite precursors (e.g., PREGNENOLONE). (See all compounds classified as Neurosteroids.)


Anesthetics

Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)


4.2 ATC Code

N - Nervous system

N01 - Anesthetics

N01A - Anesthetics, general

N01AX - Other general anesthetics

N01AX05 - Alfaxalone


Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Taste Masking

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Solubilizers

read-more
read-more

Topical

read-more
read-more

Controlled & Modified Release

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty